InvoX Pharma
高管
查看带有其 38 名主要高管的组织结构图
InvoX Pharma 搜索最多的简介
高管在InvoX Pharma变化
- Michelle Morrow, Head of Therapeutic Innovation, 已经离开公司 (新闻发布的2024十月16号).
创建提醒
跟踪 InvoX Pharma 的高管变动
药店
InvoX Pharma 拥有 1,842 家竞争者，其中包括 Pfizer (美国(美洲))、Johnson & Johnson (美国(美洲)) 和 Sanofi (法国)。
Popular M&A news in 药店
- BeiGene将改名为BeOne Medicines。 (公布2024十一月15号).
- GlycoMimetics and Crescent Biopharma have announced they will merge (公布2024十一月15号)..
- Grace Therapeutics将在Oct 25, 2024将其名称改为Grace Therapeutics。 (公布2024十月27号).
药店 行业的其他推荐联系人
消息
InvoX Pharma 的最新新闻稿
- Event Archives - invox Pharma
- invoX Pharma Presents Positive Clinical Data from Phase 1 Study of FS222 in Patients with Advanced Solid Tumours at the 2024 American Society of Clinical Oncology Annual Meeting - invox Pharma
- invoX Pharma and Insilico Medicine Enter into Collaboration to Enhance Research and Development using Artificial Intelligence - invox Pharma
- Softhale certified to ISO 13485 - invox Pharma
- Licensing Archives - invox Pharma
- F-star, an invoX Company, Announces Strategic Collaboration and LicenceAgreement with Takeda to Discover and Develop Next-Generation Multi-Specific Antibodies - invox Pharma
- F-star, an invoX Company, Announces Strategic Collaboration and LicenceAgreement with Takeda to Discover and Develop Next-Generation Multi-Specific Antibodies - invox Pharma
- Investment Archives - invox Pharma
- invoX Pharma Increases Investment in pHion Therapeutics to Further Develop Next Generation of mRNA Vaccines - invox Pharma
- News - invox Pharma
- View more press releases Close
关于 InvoX Pharma 的社交媒体
保持联系
通过电子邮件联系联系该企业高管，包括 Ben Toogood 
